
ChemoTech is a R&D based company in the field of oncology. The Company is presently marketing and selling it's IQwave™ TSE (Tumour Specific Electroporation™) system which is an innovation within the field of electroporation. ChemoTech's products are presently available in Europe, India and South East Asia. The treatment is developed to treat patients with large and 'hard to treat' superficial tumours. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm. The Company is headquartered in Lund, Sweden. We have also a device for our Animal Care division called vetIQure™,…
Annual Revenue$1M to $5M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.